- Home
- DM vs INCR Comparison
DM vs INCR Comparison
Compare DM & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DM
- INCR
- Stock Information
- Founded
- DM 2015
- INCR 1994
- Country
- DM United States
- INCR Israel
- Employees
- DM N/A
- INCR N/A
- Industry
- DM Industrial Machinery/Components
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- DM Technology
- INCR Health Care
- Exchange
- DM Nasdaq
- INCR Nasdaq
- Market Cap
- DM 87.7M
- INCR 76.7M
- IPO Year
- DM N/A
- INCR N/A
- Fundamental
- Price
- DM $4.93
- INCR $1.37
- Analyst Decision
- DM Hold
- INCR
- Analyst Count
- DM 1
- INCR 0
- Target Price
- DM $5.50
- INCR N/A
- AVG Volume (30 Days)
- DM 3.4M
- INCR 15.9K
- Earning Date
- DM 05-08-2025
- INCR 04-08-2025
- Dividend Yield
- DM N/A
- INCR N/A
- EPS Growth
- DM N/A
- INCR N/A
- EPS
- DM N/A
- INCR N/A
- Revenue
- DM $168,283,000.00
- INCR $72,420,918.00
- Revenue This Year
- DM N/A
- INCR N/A
- Revenue Next Year
- DM $6.25
- INCR $39.30
- P/E Ratio
- DM N/A
- INCR N/A
- Revenue Growth
- DM N/A
- INCR N/A
- 52 Week Low
- DM $1.84
- INCR $1.17
- 52 Week High
- DM $11.80
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- DM 81.39
- INCR 31.26
- Support Level
- DM $2.18
- INCR $1.37
- Resistance Level
- DM $2.79
- INCR $1.49
- Average True Range (ATR)
- DM 0.29
- INCR 0.06
- MACD
- DM 0.32
- INCR -0.01
- Stochastic Oscillator
- DM 96.93
- INCR 15.94
About DM Desktop Metal Inc.
Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.